OMNI BIO PHARMACEUTICAL, INC.
company.status.inactiveCIK 1389870fmd_12ZT8AECJEDGHBA1G9ZHHMVJMEManufacturing · Biological Products, (No Diagnostic Substances)Template: Standard
Coverage: Apr 01, 2006 to Dec 31, 2014, 23 periods
Latest annual · FY2014
Millions- Operating income
- (2)
- Net income
- (3)
Latest quarter · Q3 FY2015
Millions- Operating income
- (1)
- Net income
- (1)
Key stats
Open AnalysisCompound annual growth
- Net income, 5 yearsFY2009 to FY2014
- n/m
OMNI BIO PHARMACEUTICAL, INC. financials: quick answers
Annual figures as filed with the SEC. Each number links to the filing it came from and to its proof.
| Metric | FY2014 | FY2013 | Change | Source |
|---|---|---|---|---|
| Operating income | -$1.9 million | -$5.7 million | 10-K 2014-06-16 · proof | |
| Net income | -$2.5 million | -$7.5 million | 10-K 2014-06-16 · proof | |
| Cash from operating activities | -$1.4 million | -$1.7 million | 10-K 2014-06-16 · proof | |
| Total assets | $496,981 | $699,051 | -28.9% | 10-K 2014-06-16 · proof |
| Total liabilities | $1.4 million | $1.3 million | +5.9% | 10-K 2014-06-16 · proof |
| Cash and cash equivalents | $271,427 | $343,279 | -20.9% | 10-K 2014-06-16 · proof |
- What was OMNI BIO PHARMACEUTICAL, INC.'s operating income in fiscal 2014?
- OMNI BIO PHARMACEUTICAL, INC. reported operating income of -$1.9 million for fiscal 2014 (the year ended Mar 31, 2014), against -$5.7 million the year before. Source: the 10-K filed with the SEC on Jun 16, 2014. SEC
- What was OMNI BIO PHARMACEUTICAL, INC.'s net income in fiscal 2014?
- OMNI BIO PHARMACEUTICAL, INC. reported net income of -$2.5 million for fiscal 2014 (the year ended Mar 31, 2014), against -$7.5 million the year before. Source: the 10-K filed with the SEC on Jun 16, 2014. SEC
- What was OMNI BIO PHARMACEUTICAL, INC.'s cash from operating activities in fiscal 2014?
- OMNI BIO PHARMACEUTICAL, INC. reported cash from operating activities of -$1.4 million for fiscal 2014 (the year ended Mar 31, 2014), against -$1.7 million the year before. Source: the 10-K filed with the SEC on Jun 16, 2014. SEC
- What are OMNI BIO PHARMACEUTICAL, INC.'s total assets?
- As of Mar 31, 2014, OMNI BIO PHARMACEUTICAL, INC. reported total assets of $496,981, against $699,051 a year earlier (-28.9%). Source: the 10-K filed with the SEC on Jun 16, 2014. SEC
- What are OMNI BIO PHARMACEUTICAL, INC.'s total liabilities?
- As of Mar 31, 2014, OMNI BIO PHARMACEUTICAL, INC. reported total liabilities of $1.4 million, against $1.3 million a year earlier (+5.9%). Source: the 10-K filed with the SEC on Jun 16, 2014. SEC
- What are OMNI BIO PHARMACEUTICAL, INC.'s cash and cash equivalents?
- As of Mar 31, 2014, OMNI BIO PHARMACEUTICAL, INC. reported cash and cash equivalents of $271,427, against $343,279 a year earlier (-20.9%). Source: the 10-K filed with the SEC on Jun 16, 2014. SEC
Read from the FinancialMD API on Nov 13, 2026. Values change only when a new filing is made; see the Financials tab for every period and as-of replay.
The same numbers for an agent, with proof on every value:
curl "https://api.financial.md/v1/company/financials/income_statement/standardized?company=cik:1389870&period_type=annual&limit=5"Information only, not investment advice.